COVID-19 and Thromboinflammation: Is There a Role for Statins?
Open Access
Abstract
The novel coronavirus disease (COVID-19) showed increased morbidity and mortality rates and worse prognosis in individuals with underlying chronic diseases, especially cardiovascular disease and its risk factors, such as hypertension, diabetes, and obesity. ...Keywords
This publication has 100 references indexed in Scilit:
- Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: Biochemical regulatory mechanismsThrombosis Research, 2013
- Statins as Antithrombotic DrugsCirculation, 2013
- Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2Circulation, 2012
- Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate StudyThe Journal of Infectious Diseases, 2011
- Statin use and the prevention of venous thromboembolism: a meta-analysisInternational Journal Of Clinical Practice, 2010
- A Randomized Trial of Rosuvastatin in the Prevention of Venous ThromboembolismNew England Journal of Medicine, 2009
- Different Effect of Statins on Platelet Oxidized-LDLReceptor (CD36 and LOX-1) Expressionin Hypercholesterolemic SubjectsClinical and Applied Thrombosis/Hemostasis, 2005
- Statins and Blood CoagulationArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Vastatins Inhibit Tissue Factor in Cultured Human MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 1997